Literature DB >> 27473416

A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency.

Soesma A Jankipersadsing1,2, Fatemeh Hadizadeh3,4, Marc Jan Bonder2, Ettje F Tigchelaar2,5, Patrick Deelen2,6, Jingyuan Fu1,2, Anna Andreasson7,8, Lars Agreus7, Susanna Walter9, Cisca Wijmenga2, Pirro Hysi10, Mauro D'Amato3,11, Alexandra Zhernakova2,6.   

Abstract

Entities:  

Keywords:  CYTOCHROME P450; GENETICS; INTESTINAL MOTILITY; META-ANALYSIS

Mesh:

Substances:

Year:  2016        PMID: 27473416      PMCID: PMC5529970          DOI: 10.1136/gutjnl-2016-312398

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
Stool consistency and frequency patterns are complex traits that are often altered in GI disease, and recent studies published in Gut highlight the importance of stool frequency in relation to gut microbiota composition and the efficacy of pharmacological and dietary treatments in IBS.1–3 Despite reported heritability in invertebrates4 and similar evidence from open-field defaecation models in rats,5 the genetics of stool frequency has not been explored in humans. We undertook a genome-wide association study (GWAS) in two well-characterised population-based cohorts with genotype and defaecation data available: LifeLines-Deep (LLD) from the Netherlands (N=1546; 58% females; mean age 44 years (range 18–86)) and PopCol (PC) from Sweden (N=284; 60% females; mean age 54 years (range 22–71)).6 7 The average number of bowel movements per day (BM/d) was extracted from daily records kept by both populations and did not differ between cohorts (LLD=1.39±0.64SD; PC=1.42±0.74SD). Available CytoChip+Immunochip (LLD) and HumanOmniExpressExome (PC) Illumina single-nucleotide polymorphism (SNP) genotype data were imputed using IMPUTE2 (https://mathgen.stats.ox.ac.uk/impute/impute_v2.html) with the Genome of the Netherlands (http://www.nlgenome.nl/) as reference. SNPs were filtered on minor allele frequency >0.05 and Hardy–Weinberg equilibrium p>1E-04, samples were filtered on infoscore ≥0.8 and population outliers were excluded using principal component analysis. In total, high-quality genotype data for 5 390 800 common SNPs and BM/d information were obtained for 1022 LLD and 259 PC individuals. Genotype–BM/d association tests were performed in SNPTEST (https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html) using logistic regression under an additive model correcting for age and sex, followed by a fixed-effect model meta-analysis with META (https://mathgen.stats.ox.ac.uk/genetics_software/meta/meta.html). Summary statistics for the top-10 loci from the meta-analysis and the corresponding effect of associated alleles on the frequency (increased/decreased) of defaecation are given in figure 1.
Figure 1

Manhattan plot of the results from the meta-analysis of LifeLines-Deep (LLD) and PopCol (PC) genome-wide association studies. Single-nucleotide polymorphisms (SNPs) which are sorted according to their genomic positions are displayed on the X-axis, and the negative logarithm of the association p value for each SNP after meta-analysis is displayed on the Y-axis; each dot represents a SNP with a certain p value. The top-10 loci are indicated by numbers. Per locus, the statistics of the lead SNPs are shown, including the positions in the genome, the nearest genes and the genes in a 250 kb window around the lead SNPs. The effect of the assessed allele at each locus is indicated by beta; negative betas mean negative effect on the average number of bowel movements per day (BM/d) (decreased number of stool passes) and positive betas mean positive effect on the average number of BM/d (increased number of stool passes). Beta, direction of association; BP, base pair position; Chr, chromosome; SE, SE of the beta.

Manhattan plot of the results from the meta-analysis of LifeLines-Deep (LLD) and PopCol (PC) genome-wide association studies. Single-nucleotide polymorphisms (SNPs) which are sorted according to their genomic positions are displayed on the X-axis, and the negative logarithm of the association p value for each SNP after meta-analysis is displayed on the Y-axis; each dot represents a SNP with a certain p value. The top-10 loci are indicated by numbers. Per locus, the statistics of the lead SNPs are shown, including the positions in the genome, the nearest genes and the genes in a 250 kb window around the lead SNPs. The effect of the assessed allele at each locus is indicated by beta; negative betas mean negative effect on the average number of bowel movements per day (BM/d) (decreased number of stool passes) and positive betas mean positive effect on the average number of BM/d (increased number of stool passes). Beta, direction of association; BP, base pair position; Chr, chromosome; SE, SE of the beta. Although none of these associations achieved genome-wide significance (possibly due to limited sample size), we found excellent functional candidates mapping to these regions. For instance, the second strongest signal included the ALDH1A1 gene, which belongs to the family of aldehyde dehydrogenases, and another member of this family (ALDH1AL1) has been shown to affect human gut microbiota composition.8 Moreover, Gene Network coexpression analysis (http://www.genenetwork.nl/genenetwork/) indicated a role for ALDH1A1 in the cytochrome P450 metabolism of drugs and xenobiotics, and other genes in this pathway also map to top BM/d GWAS loci: the rs735320 signal comes from SNPs in the CYP8B1 gene, which belongs to the cytochrome P450 family; the rs4090 286 locus contains CYB5R2 (cytochrome B5 reductase), which is involved in cholesterol biosynthesis, fatty acid desaturation and elongation; and the rs1979097 locus contains AHR (ligand-activated aryl hydrocarbon receptor), which is a transcription factor modulating gene expression along the cytochrome P450 pathway. The genetic implication of xenobiotic and P450 metabolic pathways is not unexpected, given the interactions linking diet, gut microbiome and pharmaceutical compounds to known effects on human defaecation patterns, but was not reported previously. A broader pathway analysis (http://129.125.135.180:8080/GeneNetwork/pathway.html), including genes from all 53 loci with p<5E-05, identified the sodium channel complex and voltage-gated sodium channel activity as the most enriched pathways in Gene Ontology (GO) terms for cellular component and molecular function, respectively (table 1). This is remarkable, since genetic defects in the voltage-gated channel SCN5A have been found in a subset of patients with IBS, and normal stool frequency was restored in a severely constipated SCN5A mutant carrier treated with mexiletine, a drug able to rescue SCN5A expression.9
Table 1

Pathway analysis of GWAS meta-analysis results for the average number of BM/d

Top associated GO termp Value
Cellular component
 Sodium channel complex6E-07
 Sarcolemma2E-05
 Voltage-gated sodium channel complex2E-05
 Ion channel complex6E-05
Molecular function
 Voltage-gated sodium channel activity2E-05
 Peptidase regulator activity3E-05
 Substrate-specific channel activity4E-05
 Ion channel activity4E-05
 Passive transmembrane transporter activity7E-05
 Channel activity7E-05
 Endopeptidase inhibitor activity8E-05

Only GO pathways with p<1E-04 are reported.

BM/d, bowel movements per day; GO, Gene Ontology; GWAS, genome-wide association study.

Pathway analysis of GWAS meta-analysis results for the average number of BM/d Only GO pathways with p<1E-04 are reported. BM/d, bowel movements per day; GO, Gene Ontology; GWAS, genome-wide association study. In conclusion, we report the first GWAS of stool frequency in two harmonised population-based cohorts from the Netherlands and Sweden and highlight plausible candidate genes and biological pathways. Although we are not aware of similar datasets in which our findings may be replicated, the growing interest in this research area warrants larger studies to reach unequivocal conclusions.
  9 in total

Review 1.  The Maudsley Reactive and Nonreactive strains: a new perspective.

Authors:  David A Blizard; Nelson Adams
Journal:  Behav Genet       Date:  2002-09       Impact factor: 2.805

Review 2.  What keeps C. elegans regular: the genetics of defecation.

Authors:  Robyn Branicky; Siegfried Hekimi
Journal:  Trends Genet       Date:  2006-09-05       Impact factor: 11.639

3.  Stool frequency is associated with gut microbiota composition.

Authors:  Fatemeh Hadizadeh; Susanna Walter; Meriem Belheouane; Ferdinando Bonfiglio; Femke-Anouska Heinsen; Anna Andreasson; Lars Agreus; Lars Engstrand; John F Baines; Joseph Rafter; Andre Franke; Mauro D'Amato
Journal:  Gut       Date:  2016-04-28       Impact factor: 23.059

4.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.

Authors:  Arthur Beyder; Amelia Mazzone; Peter R Strege; David J Tester; Yuri A Saito; Cheryl E Bernard; Felicity T Enders; Weronica E Ek; Peter T Schmidt; Aldona Dlugosz; Greger Lindberg; Pontus Karling; Bodil Ohlsson; Maria Gazouli; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Michael Camilleri; G Richard Locke; Nicholas J Talley; Mauro D'Amato; Michael J Ackerman; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2014-03-05       Impact factor: 22.682

5.  Assessment of normal bowel habits in the general adult population: the Popcol study.

Authors:  Susanna A Walter; Lars Kjellström; Henry Nyhlin; Nicholas J Talley; Lars Agréus
Journal:  Scand J Gastroenterol       Date:  2010-05       Impact factor: 2.423

6.  The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS.

Authors:  J Tack; K Schumacher; G Tonini; S Scartoni; A Capriati; C A Maggi
Journal:  Gut       Date:  2016-04-15       Impact factor: 23.059

7.  FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.

Authors:  Keith McIntosh; David E Reed; Theresa Schneider; Frances Dang; Ammar H Keshteli; Giada De Palma; Karen Madsen; Premysl Bercik; Stephen Vanner
Journal:  Gut       Date:  2016-03-14       Impact factor: 23.059

8.  Genetic Determinants of the Gut Microbiome in UK Twins.

Authors:  Julia K Goodrich; Emily R Davenport; Michelle Beaumont; Matthew A Jackson; Rob Knight; Carole Ober; Tim D Spector; Jordana T Bell; Andrew G Clark; Ruth E Ley
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

9.  Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics.

Authors:  Ettje F Tigchelaar; Alexandra Zhernakova; Jackie A M Dekens; Gerben Hermes; Agnieszka Baranska; Zlatan Mujagic; Morris A Swertz; Angélica M Muñoz; Patrick Deelen; Maria C Cénit; Lude Franke; Salome Scholtens; Ronald P Stolk; Cisca Wijmenga; Edith J M Feskens
Journal:  BMJ Open       Date:  2015-08-28       Impact factor: 2.692

  9 in total
  9 in total

Review 1.  The Relationship Between the Human Genome and Microbiome Comes into View.

Authors:  Julia K Goodrich; Emily R Davenport; Andrew G Clark; Ruth E Ley
Journal:  Annu Rev Genet       Date:  2017-09-20       Impact factor: 16.830

Review 2.  Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.

Authors:  Michael Camilleri; Alexandra Zhernakova; Isotta Bozzarelli; Mauro D'Amato
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-10       Impact factor: 73.082

3.  Neuronal programming by microbiota regulates intestinal physiology.

Authors:  Brigitta Stockinger; Andrew J Macpherson; Vassilis Pachnis; Yuuki Obata; Álvaro Castaño; Stefan Boeing; Ana Carina Bon-Frauches; Candice Fung; Todd Fallesen; Mercedes Gomez de Agüero; Bahtiyar Yilmaz; Rita Lopes; Almaz Huseynova; Stuart Horswell; Muralidhara Rao Maradana; Werend Boesmans; Pieter Vanden Berghe; Andrew J Murray
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

4.  Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.

Authors:  Ferdinando Bonfiglio; Tenghao Zheng; Koldo Garcia-Etxebarria; Fatemeh Hadizadeh; Luis Bujanda; Francesca Bresso; Lars Agreus; Anna Andreasson; Aldona Dlugosz; Greger Lindberg; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Magnus Simren; Susanna Walter; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Anna Latiano; Matthias Hübenthal; Vincent Thijs; Mihai G Netea; Daisy Jonkers; Lin Chang; Emeran A Mayer; Mira M Wouters; Guy Boeckxstaens; Michael Camilleri; Andre Franke; Alexandra Zhernakova; Mauro D'Amato
Journal:  Gastroenterology       Date:  2018-04-05       Impact factor: 22.682

Review 5.  The enteric nervous system in gastrointestinal disease etiology.

Authors:  Amy Marie Holland; Ana Carina Bon-Frauches; Daniel Keszthelyi; Veerle Melotte; Werend Boesmans
Journal:  Cell Mol Life Sci       Date:  2021-03-26       Impact factor: 9.261

6.  Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins.

Authors:  Amelia Mazzone; Simon J Gibbons; Seth T Eisenman; Peter R Strege; Tenghao Zheng; Mauro D'Amato; Tamas Ordog; Martin E Fernandez-Zapico; Gianrico Farrugia
Journal:  FASEB J       Date:  2019-02-25       Impact factor: 5.834

7.  TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M.

Authors:  Maria Henström; Fatemeh Hadizadeh; Arthur Beyder; Ferdinando Bonfiglio; Tenghao Zheng; Ghazaleh Assadi; Joseph Rafter; Luis Bujanda; Lars Agreus; Anna Andreasson; Aldona Dlugosz; Greger Lindberg; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Nicholas J Talley; Magnus Simren; Susanna Walter; Mira Wouters; Gianrico Farrugia; Mauro D'Amato
Journal:  Gut       Date:  2016-12-14       Impact factor: 23.059

8.  Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity.

Authors:  Williams Turpin; Orlaith Kelly; Krzysztof Borowski; Karen Boland; Andrea Tyler; Zane Cohen; Kenneth Croitoru; Mark S Silverberg
Journal:  Clin Transl Gastroenterol       Date:  2019-05-22       Impact factor: 4.488

9.  GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome.

Authors:  Ferdinando Bonfiglio; Xingrong Liu; Christopher Smillie; Anita Pandit; Alexander Kurilshikov; Rodrigo Bacigalupe; Tenghao Zheng; Hieu Nim; Koldo Garcia-Etxebarria; Luis Bujanda; Anna Andreasson; Lars Agreus; Susanna Walter; Gonçalo Abecasis; Chris Eijsbouts; Luke Jostins; Miles Parkes; David A Hughes; Nicholas Timpson; Jeroen Raes; Andre Franke; Nicholas A Kennedy; Aviv Regev; Alexandra Zhernakova; Magnus Simren; Michael Camilleri; Mauro D'Amato
Journal:  Cell Genom       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.